Multistep solution-phase parallel synthesis of spiperone analogues.

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Organic Synthesis

Background:

• Spiperone is a well-known antagonist for dopamine D2 and serotonin 5-HT2 receptors.
• Development of novel analogues with improved selectivity is crucial for targeted therapeutic applications.
• Existing synthesis methods may lack flexibility for generating diverse analogue libraries.

Purpose of the Study:

• To develop a flexible, parallel synthesis strategy for novel spiperone analogues.
• To create a library of oxa-series spiperone analogues with diverse 4-substituted piperidine moieties.
• To evaluate the receptor binding profiles of the synthesized analogues, focusing on 5-HT2 and D2 receptors.

Main Methods:

• Multistep parallel synthesis involving reductive amination and acylation to build a 4-substituted piperidine library.
• Homogeneous or heterogeneous alkylation exploiting a product release only concept for analogue synthesis.
• Radioligand binding assays to screen synthesized compounds at serotonin 5-HT2 subtypes and dopamine D2 receptors.

Main Results:

• Successful synthesis of a library of oxa-series spiperone analogues.
• Identification of compounds exhibiting potent antagonism at the 5-HT2A receptor.
• Demonstrated improved selectivity for 5-HT2A receptors compared to the parent compound spiperone and AMI-193.

Conclusions:

• The described synthetic approach provides a flexible platform for generating spiperone analogues.
• The novel analogues represent promising candidates for selective 5-HT2A receptor antagonism.
• These findings contribute to the development of more targeted therapeutics for central nervous system disorders.